BRISTOL Competitors

Stocks . USA . 
Stock . BRISTOL MYERS SQUIBB
BRISTOL MYERS SQUIBB competes with CbdMD, Dogwood Therapeutics,, VSee Health,, Kindly MD,, and AptarGroup; as well as few others. Analyzing BRISTOL MYERS competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of BRISTOL MYERS to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of BRISTOL MYERS competition on your existing holdings.
  
Specify up to 10 symbols:
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BRISTOL MYERS. Your research has to be compared to or analyzed against BRISTOL MYERS's peers to derive any actionable benefits. When done correctly, BRISTOL MYERS's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BRISTOL MYERS SQUIBB.

BRISTOL MYERS Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between BRISTOL MYERS and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of BRISTOL and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of BRISTOL MYERS SQUIBB does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
IRD
+ 0.74
KDLYW
IRD
+ 0.7
DWTX
CEROW
+ 0.69
EPRX
KDLYW
+ 0.53
DWTX
ATR
+ 0.5
YCBD-PA
ATR
+ 0.48
EPRX
  
High negative correlations   
IRD
- 0.69
EPRX
KDLYW
- 0.67
EPRX
CEROW
- 0.64
DWTX
EPRX
- 0.63
DWTX
ATR
- 0.57
KDLYW
IRD
- 0.56
CEROW

Risk-Adjusted Indicators

There is a big difference between BRISTOL Stock performing well and BRISTOL MYERS Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BRISTOL MYERS's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

BRISTOL MYERS Competitive Analysis

The better you understand BRISTOL MYERS competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, BRISTOL MYERS's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across BRISTOL MYERS's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
YCBD-PA DWTX VSEE EPRX CEROW KDLYW ATR IRD
 2.78 
 0.74 
CbdMD
 5.51 
 2.87 
Dogwood
 4.32 
 1.33 
VSee
 0.97 
 3.06 
Eupraxia
 0.000005 
 0.01 
CERo
 5.00 
 0.19 
Kindly
 0.00 
 159.35 
AptarGroup
 1.92 
 1.02 
Opus
Market Volatility
(90 Days Market Risk)
Out of control
Extremely Dangerous
Abnormally volatile
Very risky
Out of control
Out of control
Very steady
Abnormally volatile
Market Performance
(90 Days Performance)
Insignificant
Very Weak
Weak
Modest
Good
OK
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
High
Very High
Below Average
Unknown
Quite High
High
Very Low
High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Not Available
Not Available
Not Available
Not Available
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Hold
Strong Sell
Current Ratio
3.47 X
N/A
N/A
N/A
N/A
1.56 X
N/A
Net Asset
40.79 M
4.17 M
830.79 K
8.56 M
1.1 M
4.45 B
53.95 M
Profit Margin
(1.98) %
N/A
(0.52) %
N/A
N/A
0.09 %
N/A
EBITDA
(70.06 M)
N/A
(2.24 M)
(2.44 M)
(1.36 M)
663.84 M
N/A
Operating Margin
(0.49) %
N/A
0.04 %
N/A
N/A
0.16 %
N/A
Current Valuation
350.88 M
N/A
23.57 M
N/A
N/A
11.41 B
N/A
Price To Book
N/A
N/A
359.54 X
N/A
N/A
4.18 X
N/A
Retained Earnings
N/A
(61.47 M)
(9.11 M)
(14.2 M)
(4.16 M)
2.11 B
(81.47 M)
Current Asset
N/A
N/A
N/A
N/A
N/A
519.72 M
N/A
Five Year Return
N/A
N/A
N/A
N/A
N/A
1.27 %
N/A
Beta
2.24
N/A
-0.054
-0.46
N/A
0.57
N/A
Number Of Employees
90
4
N/A
8
23
13 K
14
Shares Outstanding
N/A
N/A
14.82 M
N/A
N/A
66.54 M
N/A
Cash Flow From Operations
(14.09 M)
N/A
(632.6 K)
(1.52 K)
(449.49 K)
575.24 M
(1.11 M)
Annual Yield
0.08 %
N/A
N/A
N/A
N/A
0.01 %
N/A
Total Debt
5.15 M
358.55 K
543 K
1.55 M
636.38 K
1.18 B
4.04 M
Return On Equity
-1.04
N/A
N/A
N/A
N/A
0.14
N/A
Z Score
-3.3
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.13
N/A
-0.24
-0.45
N/A
0.0701
N/A
Book Value Per Share
0.52 X
N/A
(0.31) X
(2.27) X
N/A
38.18 X
N/A
Number Of Shares Shorted
N/A
N/A
386.98 K
18.44 K
N/A
422.63 K
N/A
Current Liabilities
N/A
N/A
N/A
N/A
N/A
411.89 M
N/A
Total Asset
40.79 M
4.17 M
830.79 K
8.56 M
1.1 M
4.45 B
53.95 M
Debt To Equity
0.11 %
N/A
N/A
N/A
N/A
0.63 %
N/A
Short Ratio
N/A
N/A
0.02 X
N/A
N/A
1.61 X
N/A
Target Price
N/A
N/A
N/A
N/A
N/A
188.0
N/A
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
1.68
N/A
Shares Owned By Institutions
9.69 %
N/A
3.44 %
N/A
N/A
92.74 %
N/A
Market Capitalization
N/A
N/A
23.71 M
N/A
N/A
10.6 B
N/A
Price To Earning
N/A
N/A
N/A
N/A
N/A
28.95 X
N/A
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
2.47 X
N/A
Price To Sales
N/A
N/A
4.13 X
N/A
N/A
2.97 X
N/A
Net Income
(70.08 M)
(5.3 M)
(3.45 M)
(2.54 K)
(1.62 M)
284.18 M
(9.99 M)
Earnings Per Share
(0.50) X
N/A
(0.06) X
N/A
N/A
4.99 X
N/A
Shares Owned By Insiders
N/A
N/A
68.40 %
N/A
N/A
0.56 %
N/A
Revenue
35.4 M
N/A
5.84 M
N/A
3.77 M
3.49 B
19.05 M
Working Capital
N/A
3.81 M
N/A
5.91 M
(197.52 K)
297.97 M
49.91 M
Cash And Equivalents
10.55 M
N/A
N/A
N/A
N/A
141.73 M
N/A
Cash Per Share
0.17 X
N/A
N/A
N/A
N/A
1.91 X
N/A
Gross Profit
22.34 M
N/A
N/A
N/A
N/A
1.16 B
N/A
Day Typical Price
0.72
2.75
1.34
3.06
0.0079
0.17
158.9
1.02
Accumulation Distribution
0.0811
0.13
0.0507
N/A
0.0125
0.26
0.0094
0.0667
Market Facilitation Index
0.06
0.38
0.07
N/A
1.0E-4
0.05
1.5
0.07
Daily Balance Of Power
0.3333
0.3947
(0.86)
(9,223,372,036,855)
(0.000004)
(0.20)
N/A
(0.29)
Period Momentum Indicator
0.02
0.15
(0.06)
(0.03)
N/A
(0.01)
N/A
(0.02)
Rate Of Daily Change
1.03
1.06
0.96
0.99
1.0
0.95
1.0
0.98
Day Median Price
0.71
2.69
1.35
3.06
0.008
0.17
158.67
1.02
Price Action Indicator
0.04
0.26
(0.04)
(0.01)
(0.00005)
0.02
0.68
(0.01)
Coefficient Of Variation
1248.04
(11,177)
(19,054)
2031.79
728.62
1550.49
2616.9
(2,158)
Mean Deviation
3.78
7.93
5.31
3.66
26.48
12.53
0.7614
3.87
Jensen Alpha
0.4546
(0.15)
(0.03)
0.2686
5.03
1.33
0.0073
(0.35)
Total Risk Alpha
0.1907
(0.62)
(0.40)
0.0208
3.37
0.4187
(0.02)
(0.51)
Sortino Ratio
0.0663
N/A
N/A
0.0507
0.1876
0.0551
(0)
N/A
Downside Variance
35.23
N/A
N/A
18.45
682.1
530.87
1.78
N/A
Standard Deviation
5.47
11.69
7.92
5.33
36.03
20.36
1.12
5.54
Kurtosis
1.79
3.39
6.6
5.49
3.03
3.26
4.38
2.55
Potential Upside
10.77
16.24
16.22
10.43
66.67
33.33
1.42
8.91
Treynor Ratio
(0.57)
(0.13)
0.0685
(0.55)
(1.73)
(1.44)
0.0447
(0.11)
Maximum Drawdown
30.15
69.76
50.39
34.56
191.74
120.55
7.86
29.54
Variance
29.95
136.59
62.7
28.45
1297.98
414.64
1.26
30.69
Market Risk Adjusted Performance
(0.56)
(0.12)
0.0785
(0.54)
(1.72)
(1.43)
0.0547
(0.1)
Risk Adjusted Performance
0.0726
0.0022
0.0048
0.0479
0.1195
0.0612
0.0334
(0.03)
Skewness
0.4496
0.2318
1.95
1.6
1.38
0.9405
(0.99)
0.6802
Semi Deviation
4.53
N/A
N/A
3.84
22.51
14.53
1.27
N/A
Information Ratio
0.072
(0.01)
(0.01)
0.0408
0.136
0.0623
(0)
(0.05)
Value At Risk
(8.00)
(18.49)
(8.82)
(6.39)
(40.00)
(30.00)
(1.57)
(8.79)
Expected Short fall
(4.89)
N/A
N/A
(4.74)
(35.78)
(21.98)
(0.72)
N/A
Downside Deviation
5.94
N/A
N/A
4.29
26.12
23.04
1.33
N/A
Semi Variance
20.5
N/A
N/A
14.78
506.69
211.01
1.61
N/A

BRISTOL MYERS Competition Performance Charts

Five steps to successful analysis of BRISTOL MYERS Competition

BRISTOL MYERS's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by BRISTOL MYERS SQUIBB in relation to its competition. BRISTOL MYERS's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of BRISTOL MYERS in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact BRISTOL MYERS's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to BRISTOL MYERS SQUIBB, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your BRISTOL MYERS position

In addition to having BRISTOL MYERS in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Health Management Thematic Idea Now

Health Management
Health Management Theme
Major hospitals and healthcare providers. The Health Management theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Management Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Tools for BRISTOL Stock

When running BRISTOL MYERS's price analysis, check to measure BRISTOL MYERS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BRISTOL MYERS is operating at the current time. Most of BRISTOL MYERS's value examination focuses on studying past and present price action to predict the probability of BRISTOL MYERS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BRISTOL MYERS's price. Additionally, you may evaluate how the addition of BRISTOL MYERS to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY